Exactech Inc hits 2 month low after guidance announcement |
 |
 |
| By Staff and Wire Reports |
| Wednesday, 08 July 2009 16:44 |
 Exactech Inc. (NASDAQ:EXAC) announced after the bell Wednesday that it now expects to report second quarter revenues of approximately $43 million.
Earnings for the quarter are also expected to be below prior guidance. The company also adjusted its revenue forecast for the full year 2009 to between $167 million and $173 million. Shares are now down 0.77 on 17K shares. Exactech Inc. declined for the bulk of Wednesday morning and slipped further going into the close. The stock finished down by 0.66 at $13.52 and set a 2-month low. BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section Add this page to your favorite Social Bookmarking websites            |
about 2 hours ago
Medgenics ($MDGN) up 10% on Monday! We first told you about the firm last Friday: http://t.co/aD50CMSH
about 2 hours ago
Thinly traded BioLineRx shares move on hepatitis C deal: The shares of thinly traded BioLineRx (NASDAQ:BLRX) soa... http://t.co/ugbuZgNN
about 7 hours ago
Orexigen® Announces Agreement From the FDA on a Special Protocol Assessment; Acorda Announces Launch of Generic ... http://t.co/vSt6VrLP
about 11 hours ago
$CVM up 17% and technically looks like it may head higher.
about 17 hours ago
$ANAC drops after GlaxoSmithKline (GSK) pauses enrollment for its clinical trials of its urinary tract infection drug. http://t.co/yUUSzkUr
about 17 hours ago
Catalysts on tap for Corcept: Corcept Therapeutics (NASDAQ:CORT) is a drug discovery company focused on the deve... http://t.co/jd3C1ddH
about 18 hours ago
Commented on: "Will Celsion's Upcoming Catalysts Help The Price Break-Out Stick?" http://t.co/dJ0reUFR $BSX $PHG $MDSO $CLSN
about 18 hours ago
Monday morning watch -- European Leaders Maintain Pressure on Greece to Complete Terms for Bailout - http://t.co/0wipY6QB via @BloombergNews
Free Phone Trade Alerts
